Royal Bank of Canada’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $677K | Buy |
|
|||||
|
2025
Q1 | $382K | Buy |
|
|||||
|
2024
Q4 | $250K | Buy |
|
|||||
|
2024
Q3 | $184K | Buy |
|
|||||
|
2024
Q2 | $145K | Buy |
|
|||||
|
2024
Q1 | $138K | Sell |
|
|||||
|
2023
Q4 | $451K | Buy |
|
|||||
|
2023
Q3 | $208K | Buy |
|
|||||
|
2023
Q2 | $141K | Buy |
|
|||||
|
2023
Q1 | $154K | Sell |
|
|||||
|
2022
Q4 | $325K | Buy |
|
|||||
|
2022
Q3 | $129K | Buy |
|
|||||
|
2022
Q2 | $42K | Sell |
|
|||||
|
2022
Q1 | $133K | Sell |
|
|||||
|
2021
Q4 | $262K | Buy |
|
|||||
|
2021
Q3 | $156K | Buy |
|
|||||
|
2021
Q2 | $138K | Buy |
|
|||||
|
2021
Q1 | $69K | Sell |
|
|||||
|
2020
Q4 | $522K | Buy |
|
|||||
|
2020
Q3 | $429K | Sell |
|
|||||
|
2020
Q2 | $496K | Sell |
|
|||||
|
2020
Q1 | $381K | Buy |
|
|||||
|
2019
Q4 | $44K | Sell |
|
|||||
|
2019
Q3 | $67K | Sell |
|
|||||
|
2019
Q2 | $901K | Sell |
|
|||||
|
2019
Q1 | $960K | Buy |
|
|||||
|
2018
Q4 | $848K | Sell |
|
|||||
|
2018
Q3 | $1.31M | Sell |
|
|||||
|
2018
Q2 | $1.75M | Buy |
|
|||||
|
2018
Q1 | $1.12M | Buy |
|
|||||
|
2017
Q4 | $948K | Sell |
|
|||||
|
2017
Q3 | $1.05M | Sell |
|
|||||
|
2017
Q2 | $11.7M | Buy |
|
|||||
|
2017
Q1 | $954K | Buy |
|
|||||
|
2016
Q4 | $764K | Buy |
|
|||||
|
2016
Q3 | $506K | Buy |
|
|||||
|
2016
Q2 | $390K | Sell |
|
|||||
|
2016
Q1 | $335K | Buy |
|
|||||
|
2015
Q4 | $173K | Buy |
|
|||||
|
2015
Q3 | $149K | Sell |
|
|||||
|
2015
Q2 | $196K | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $181K | Sell |
|
|||||
|
2014
Q2 | $281K | Buy |
|
|||||
|
2013
Q3 | – | Sell |
|
|||||
|
2013
Q2 | $0 | Buy |
|